Adicet Bio
ACET
$2.02
Share price
-10.79%
Change (1 day)
-66.14%
Change (1 year)
Categories
P/S ratio for Adicet Bio (ACET)
P/S ratio as of April 2024 (TTM): N/A
According to Adicet Bio's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2023 the company had a P/S ratio of N/A.
P/S ratio history for Adicet Bio from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | N/A | -100% |
| 2022 | 15.3 | -78.21% |
| 2021 | 70.4 | 355.64% |
| 2020 | 15.4 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 3.71 | N/A | 🇨🇭 Switzerland |
 Pfizer PFE | 2.46 | N/A | 🇺🇸 USA |
 Merck MRK | 5.28 | N/A | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 0.9135 | N/A | 🇮🇱 Israel |
 Hawkins HWKN | 1.69 | N/A | 🇺🇸 USA |
 Quaker Houghton KWR | 1.73 | N/A | 🇺🇸 USA |